Ads
related to: keytruda cost per year- Treatment Information
Learn More About What To Expect
When Taking ADSTILADRIN®.
- Support & Resources
View Patient Assistance, Coverage
Support, & Other Valuable Resources
- Discover ADSTILADRIN®
Talk To Your Doctor About If
ADSTILADRIN® Is Right For You.
- Learn About ADSTILADRIN®
Discover Important Product
And Treatment Information.
- Treatment Information
Search results
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 1 year agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
Zacks via Yahoo Finance· 1 year agoMerck MRK reported first-quarter 2023 adjusted earnings of $1.40 per share, which beat the Zacks...
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Zacks via Yahoo Finance· 1 year agoMerck MRK reported fourth-quarter 2022 adjusted earnings of $1.62 per share, which beat the Zacks...
Merck (MRK) Q4 Earnings Beat, Sales Miss, Upbeat '24 View
Zacks via Yahoo Finance· 4 months agoMerck MRK reported adjusted earnings of 3 cents per share in fourth-quarter 2023, wider than the...
Mirati's (MRTX) Q4 Loss Narrows, Krazati Records First Sales
Zacks via Yahoo Finance· 1 year agoMirati Therapeutics MRTX reported a loss of $3.51 per share for fourth-quarter 2022, narrower than...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 1 year agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...
A Bull Market Is Here: 2 Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 months agoWith the S&P 500 index recently hitting a new all-time high, we can officially declare that we are...
The Zacks Analyst Blog Highlights Merck, Thermo Fisher Scientific, American Express, Valero Energy...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – February 16, 2023 – Zacks.com announces the list of stocks...
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
Zacks via Yahoo Finance· 1 year agoFriday, December 9, 2022 The Zacks Research Daily presents the best research output of our analyst...
Seagen's (SGEN) Q1 Earnings and Revenues Miss Expectations
Zacks via Yahoo Finance· 1 year agoSeagen Inc. SGEN reported a loss of 93 cents per share in the first quarter of 2023, wider than the...
